| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 06/12/2008 | US20080139510 Treatment of migraine headaches with sublingual amino acids |
| 06/12/2008 | US20080139502 Re-epithelializing pharmaceutical compositions comprising xanthan gum |
| 06/12/2008 | US20080139482 Intermediate duration neuromuscular blocking agents and antagonists thereof |
| 06/12/2008 | US20080139481 High binding activity modified peptides; blood stability, receptor selectivity, barrier crossing; N-terminus moieties |
| 06/12/2008 | US20080138422 Analgesic agents, controlled release to provide a rapid onset of analgesic effect, also delayed and/or sustained release; amitriptyline, gabapentin; sleep disorders |
| 06/12/2008 | US20080138400 Curcumin analog or metabolite microencapsulated by a polyethylene glycolated liposome of dimyristoyl phosphatidylcholine, cholesterol, and dimyristoyl phsphatidylethanolamine; anticarcinogenic and antiproliferative agents; parenteral colloidal drug delivery system providing improved bioavailability |
| 06/12/2008 | US20080138396 rheumatoid arthritis, ulcerative colitis, Crohn's disease, inflammation, infections, osteomyelitis, atherosclerosis, organ transplant rejection, pulmonary fibrosis, sarcoidosis, and systemic sclerosis |
| 06/12/2008 | US20080138389 Contains a solvent-free matrix layer containing (-)-5,6,7,8-tetrahydro-6-[propyl-[2-(2-thienyl)ethyl]amino]-1-naphthalenol; increased solubility |
| 06/12/2008 | US20080138383 Compositions and methods for treating seizures |
| 06/12/2008 | US20080138364 Injection of botulinum toxin types A, B, C1, D, E, F or G as analgesic for diabetes- or cancer-associated pain not associated with headache or muscle spasm |
| 06/12/2008 | US20080138353 Alpha b-chrystallin as a therapy for inflammation |
| 06/12/2008 | US20080138348 G-protein coupled receptor ligands and methods |
| 06/12/2008 | US20080138329 Inhibitors of Dna Methylation in Tumor Cells |
| 06/12/2008 | US20080138321 Method for enhancing stem cell trafficking |
| 06/12/2008 | US20080138294 Drug delivery of a nicotine formulation in a single pulmonary dose; free of tobacco; multiple containers; aerosols, inhalants; may also administer an antidepressant or anxiolytic agent; smoking termination |
| 06/12/2008 | US20080138283 1,2,4-triazole- 3,5-dione derivatives; for imaging and therapy of psychiatric, eating, sleeping, bipolar disorder; anxiolytic agent, antidepressant; Alzheimer's, Parkinson's diseases, epilepsy; imaging agents for a serotonin receptor |
| 06/12/2008 | DE112006001619T5 Kristalline Base von Escitalopram und orodispersible Tabletten, die Escitalopram-Base umfassen The crystalline base of escitalopram and orodispersible tablets comprising escitalopram base |
| 06/12/2008 | CA2672120A1 Antagonistic antibodies against ephb3 |
| 06/12/2008 | CA2671524A1 Inhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration |
| 06/12/2008 | CA2671354A1 Tricyclic compound and medical use thereof |
| 06/12/2008 | CA2671324A1 Indoles which act as via receptor antagonists |
| 06/12/2008 | CA2671049A1 Stroke recovery |
| 06/12/2008 | CA2670892A1 Substituted diazepan compounds as orexin receptor antagonists |
| 06/12/2008 | CA2670886A1 Oral transmucosal nicotine dosage form |
| 06/12/2008 | CA2670788A1 A2a adenosine receptor antagonists |
| 06/12/2008 | CA2670593A1 Treatment of anxiety with eszopiclone |
| 06/12/2008 | CA2670375A1 Substituted pyrimidines and their use as jnk modulators |
| 06/12/2008 | CA2670001A1 Composition for the prevention and/or treatment of diseases associated with tnf and/or il-12 overexpression |
| 06/12/2008 | CA2669590A1 2-aminoquinolines as 5-ht(5a) receptor antagonists |
| 06/12/2008 | CA2668196A1 Substituted 2,5-dfflydro-3h-pyrazolo[4,3-c]pyridazin-3-one derivatives, preparation thereof and use of same as cannabinoid cb1 receptor ligands |
| 06/12/2008 | CA2667510A1 Methods for treating disruptive behavior disorders |
| 06/12/2008 | CA2667372A1 1,5-diphenyl-3-benzylamino-1,5-dihydropyrrolidin-2-one as cb1 receptor modulators |
| 06/12/2008 | CA2667210A1 1,5-diphenyl-3-pyridinylmethylamino-1,5-dihydropyrrolidin-2-one as a cb-1 receptor modulator |
| 06/12/2008 | CA2665924A1 Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists |
| 06/12/2008 | CA2664112A1 Novel substituted diaza-spiro-pyridinone derivatives for use in mch-1 mediated diseases |
| 06/11/2008 | EP1930439A1 Neurotrophic factors |
| 06/11/2008 | EP1930344A1 Polypeptide having anti-angiogenic activity |
| 06/11/2008 | EP1930322A1 1-(4-piperidinyl)-1,3-dihydro-2H-benzoxazole-2-one derivatives and related compounds as nociceptin analogs and ORL1 ligands for the treatment of pain |
| 06/11/2008 | EP1930308A1 Pharmaceutical agents for the treatment of cerebral amyloidosis |
| 06/11/2008 | EP1930027A2 A composition of sodium channel blocking compound |
| 06/11/2008 | EP1930023A2 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 06/11/2008 | EP1930021A2 Novel amide derivatives as growth hormone secretagogues |
| 06/11/2008 | EP1930020A1 Chinese medicinal compositions for treating headache, formulations and processes for preparation thereof |
| 06/11/2008 | EP1929999A1 Use of agomelatine to obtain medication aimed at treating Smith-Magenis Syndrome |
| 06/11/2008 | EP1929013A2 Antisense oligonucleotides against protein kinase isoforms alpha, beta and gamma |
| 06/11/2008 | EP1928905A2 Binding domains of proteins of the repulsive guidance molecule (rgm) protein family and functional fragments thereof, and their use |
| 06/11/2008 | EP1928886A1 Pyridine derivatives and their use in the treatment of psychotic disorders |
| 06/11/2008 | EP1928885A1 Fused tricyclic (mglur1) antagonists as therapeutic agents |
| 06/11/2008 | EP1928882A2 (s)-n-methylnaltrexone, process for its synthesis and its pharmaceutical use |
| 06/11/2008 | EP1928881A2 Prodrugs of active agents |
| 06/11/2008 | EP1928871A2 Bicyclic derivatives as modulators of voltage gated ion channels |
| 06/11/2008 | EP1928866A1 Substituted indazoles as inhibitors of phosphodiesterase type-iv |
| 06/11/2008 | EP1928860A1 Novel 2,3-dihydroindole compounds |
| 06/11/2008 | EP1928856A1 Quinoline compounds capable of binding the cb2 and/or the 5-ht6 receptor |
| 06/11/2008 | EP1928849A1 New crystallization process of quetiapine hemifumarate |
| 06/11/2008 | EP1928835A1 Alkyl sulfoxide quinolines as nk-3 receptor ligands |
| 06/11/2008 | EP1928834A1 Alkylnitrile quinolines, as nk-3 receptor ligands |
| 06/11/2008 | EP1928833A1 Novel quinoline compounds capable of binding at the cb2 receptor |
| 06/11/2008 | EP1928552A2 Methods and compositions for improving cognitive function |
| 06/11/2008 | EP1928488A1 Oligodendrocyte precursor cell proliferation regulated by prolactin |
| 06/11/2008 | EP1928484A2 Methods for treatment of headaches by administration of oxytocin |
| 06/11/2008 | EP1928464A2 Novel parenteral carbamazepine formulation |
| 06/11/2008 | EP1928463A2 Method of using potassium channel inhibiting compounds |
| 06/11/2008 | EP1928458A2 Use of inhibitors of the na+/h+ exchanger, subtype 5 (nhe5), to improve memory retention |
| 06/11/2008 | EP1928448A1 ASSOCIATION OF ß3 RECEPTOR AGONIST AND MONOAMINE REUPTAKE INHIBITORS, PHARMACEUTICAL COMPOSITION CONTAINING SAME AND THERAPEUTIC USE THEREOF |
| 06/11/2008 | EP1928446A2 Milnacipran for the long-term treatment of fibromyalgia syndrome |
| 06/11/2008 | EP1928443A1 2-aminoalcohols for the treatment of neurodegenerative diseases |
| 06/11/2008 | EP1928438A2 Use of ibudilast for treating drug and behavioral addictions |
| 06/11/2008 | EP1928437A2 Neurogenesis by muscarinic receptor modulation |
| 06/11/2008 | EP1928259A2 Oral composition and method for stress reduction associated with smoking cessation |
| 06/11/2008 | EP1727809B1 Substituted morpholine and thiomorpholine derivatives |
| 06/11/2008 | EP1638933B1 N-pyrrolidin-3-yl-amide derivatives as serotonin and noradrenaline re-uptake inhibitors |
| 06/11/2008 | EP1599197B1 The use of antimuscarinic drugs |
| 06/11/2008 | EP1497293B1 (1,4)diazepino(6,7,1-ij)quinoline derivatives as anti psychotic and antiobesity agents |
| 06/11/2008 | EP1497266B1 Quinoline derivatives and their use as 5-ht6 ligands |
| 06/11/2008 | EP1492803B1 New analogs of nitrobenzylthioinosine |
| 06/11/2008 | EP1443816B1 Methods of treating disorders related to apoe |
| 06/11/2008 | EP1392334B1 Therapeutic methods using herbal compositions |
| 06/11/2008 | EP1368032B1 Excitatory amino acid receptor antagonists |
| 06/11/2008 | EP1313713B1 4-pyrimidinamine derivatives, pharmaceutical compositions and related methods |
| 06/11/2008 | EP0954529B1 Porphyromonas gingivalis antigens for the diagnosis and treatment of periodontitis |
| 06/11/2008 | CN101198609A Aspartyl protease inhibitors |
| 06/11/2008 | CN101198606A Alpha-(aryl-or heteroaryl-methyl)-beta piperidino propanamide compounds as ORL1-receptor antagonists |
| 06/11/2008 | CN101198598A Compounds, compositions and methods for stabilizing transthyretin and inhibiting transthyretin misfolding |
| 06/11/2008 | CN101198583A Compounds which inhibit beta-secretase activity and methods of use |
| 06/11/2008 | CN101198582A Polymorphic crystal of 4'-{2-[ (1s, 2r) - 2- hydroxy -2- (4-hydroxyphenyl) -1- methylethylamino] ethoxy} - 3 - isopropyl-3', 5' -dimethylbiphenyl - 4 - carboxylic acid hydrochloride |
| 06/11/2008 | CN101198342A Composition for inducing sleep comprising essential oils as active ingredients, a percutaneous pharmaceutical agent comprising thereof, and a process for producing thereof |
| 06/11/2008 | CN101198331A Solubilization preparation |
| 06/11/2008 | CN101198328A Solid pharmaceutical preparation containing (R)-(-)-2-[5-(4-fluorophenyl)-3-pyridylmethylaminomethyl]-chroman |
| 06/11/2008 | CN101198323A Therapeutic combinations for the treatment or prevention of psychotic disorders |
| 06/11/2008 | CN101198322A Therapeutic combinations for the treatment or prevention of depression |
| 06/11/2008 | CN101198320A Herpesvirus-derived therapeutic agent for pain |
| 06/11/2008 | CN101195646A Production method of stilbene glycoside extract |
| 06/11/2008 | CN101195613A Compound with substituted tetratomic ring structure and medicine use thereof |
| 06/11/2008 | CN101195612A Compound with substituted cyclobutane structure, production method and medicine use thereof |
| 06/11/2008 | CN101195604A 4,5-dihydro-1H-pyrazole derivatives having potent CB1-antagonistic activity |
| 06/11/2008 | CN101195585A Compound with substituted cyclohexane structure, production method and medicine use thereof |
| 06/11/2008 | CN101195584A Compound with substituted cyclopropane structure, production method and medicine use thereof |
| 06/11/2008 | CN101195028A Compositions and methods for treating or preventing inflammatory diseases |
| 06/11/2008 | CN101195017A Chinese medicine patch for treating ache |